A Houston expert weighs in on the importance of breaking down barriers for innovation. Photo via Getty Images

Innovation has always been the driving force behind progress and development in every industry. It is the engine that propels growth, fosters competition, and improves people’s lives. The importance of innovation in every sector has grown exponentially in recent years with new ideas and technologies emerging faster than ever before. This explosion has led to innovation silos, where each industry is developing its own innovations and making progress in isolation from the others.

Houston has embraced the rise of innovation with gusto and is a prime city to break down industry specific silos. We proudly host the largest medical center and the energy capital of the world as well as the headquarters for the space race. The mayor’s office has shown a strong commitment to support rapid innovation growth, providing incentives and infrastructure for technology companies and talent to reside in Houston. Our city’s emerging innovation district has already shown huge promise with the Ion building and Greentown Labs providing a strong foundation to expand. Organizations uniting innovators across all industries like Pumps & Pipes could only exist in a city as diverse and accessible as Houston. Nonetheless, our community needs to band together to ensure innovation growth is inclusive of all industries to create an equitable approach to technology that will continue to benefit generations to come.

While innovation silos may have some benefits, such as competition and differentiation, they also have some significant drawbacks, including inefficiencies, redundancies, and missed opportunities. Industries can become so focused on their own innovations that they fail to see the potential for cross-industry collaboration. Many examples exist today where certain technologies or practices were once reserved for specific use cases and now have become mainstream. For instance, the use of the common GPS network for location and navigation services was originally pioneered by NASA, and hospital safety and quality checklists were derived from the airline industry. By soliciting more opportunities for innovation sharing, we can achieve faster growth, implement stronger and safer processes, and reduce repetitive and costly pilot testing in every industry from energy, health care, finance, social impact, and more.

I am putting out a call to action to the Houston community to open your doors to cross-industry partnerships.

Engage in more open dialogue and information sharing outside your industry.

Attend events that bring together professionals from all industries for knowledge sharing and idea exchange. Many conferences, workshops, and meet-ups already exist to unite and recognize cross-industry communities within specific interest groups. In addition, startup accelerators, incubator programs, and collaborative workspaces provide unique environments that encourage spontaneous conversations and positive idea exchange.

Incentivize businesses, start-ups, and individuals who are willing to collaborate and share their ideas with others.

Knowledge sharing should be rewarded through recognition programs, awards, special partnership opportunities, and more. Professional organizations and leadership networks are a great place to turn to for connecting with like-minded individuals and identifying recognition opportunities that can promote the great work of experience sharing.

Commit investments in cross-industry research and development.

We need to create more incentives for researchers to work across different industries and apply their expertise to various fields. Examples like the Ion Prototyping Lab, a one-of-a-kind makerspace for all, and events at the upcoming Ion Activation Festival, including “Back to the Future of Innovation”, unite researchers with industry to encourage collaborative collisions.

In the end, breaking down innovation barriers is essential if we want to continue on this upward, fast-growth trend to improve our community and to make an impact in people’s lives across the world. We need to take action now to promote a more seamless cross-industry approach to knowledge sharing, collaboration, and research and development to create a better future for all.

___

Arielle Rogg is the principal and founder of Rogg Enterprises LLC, a Houston-based company providing digital marketing for health care innovators.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.